Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Variable Rate Preferred Portfolio PS (VRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family Invesco PowerShares
  • Assets Under Management 2,097,422,000
  • Shares Outstanding, K 84,200

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.85 +0.44%
on 05/23/18
25.05 -0.36%
on 05/07/18
+0.05 (+0.20%)
since 04/25/18
3-Month
24.85 +0.44%
on 05/23/18
25.43 -1.85%
on 03/01/18
-0.27 (-1.07%)
since 02/23/18
52-Week
24.85 +0.44%
on 05/23/18
26.49 -5.76%
on 07/11/17
-0.98 (-3.78%)
since 05/25/17

Most Recent Stories

More News
Verona Pharma to Present Clinical Trial Data of RPL554 for COPD Maintenance Treatment at American Thoracic Society 2018 International Conference

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018

Announced positive top-line data from two Phase 2 clinical trials ahead of schedule

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma to Present at BioEURquity Europe 2018

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma Announces Departure of Chief Medical Officer

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or "the Company"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases,...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma to Present at Upcoming Healthcare Investor Conferences

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, today announced...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)
Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 24.96 (+0.16%)
VRNA : 16.07 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRP with:

Fund Summary

The PowerShares Variable Rate Preferred Portfolio is based on the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The Fund will generally invest at least 90% of its total assets in preferred securities that comprise the Index. The Index is a market capitalization-weighted...

See More

Key Turning Points

2nd Resistance Point 25.04
1st Resistance Point 25.00
Last Price 24.96
1st Support Level 24.91
2nd Support Level 24.86

See More

52-Week High 26.49
Fibonacci 61.8% 25.86
Fibonacci 50% 25.67
Fibonacci 38.2% 25.47
Last Price 24.96
52-Week Low 24.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar